In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2365-2370

  Odenholt, Inga ^a   Löwdin, Elisabeth ^a   Cars, Otto ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEFTRIAXONE; ERTAPENEM; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; DRUG SENSITIVITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL;

EID: 0344043396     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2365     Document Type: Article

References (25)

1. Buckley, M. M., R. N. Brogden, L. B. Barradell, and K. L. Goa. 1992. Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 4:408-444.
2. Bundtzen, R. W., A. U. Gerber, D. L. Cohn, and W. A. Craig. 1981. Postantibiotic suppression of bacterial growth. Rev. Infect. Dis. 3:28-37.
3. Bustamente, C. I., G. L. Drusano, B. A. Tatem, and H. C. Standiford. 1984. Postantibiotic effects of imipenem on Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 5:678-682.
4. Craig, W. A., and S. Gudmundsson. 1996. The postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
5. Fantin, B., S. Ebert, J. Leggett, B. Vogelman, and W. A. Craig. 1990. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. J. Antimicrob. Chemother. 27:829-836.
6. Jones, R. N., A. L. Barry, and C. Thornsberry. 1989. In-vitro studies of meropenem. J. Antimicrob. Chemother. 24(Suppl. A):9-29.
7. Labia, R., A. Morand, and M. Guionie. 1986. β-Lactamase stability of imipenem. J. Antimicrob. Chemother. 18(Suppl. E):1-8.
8. Leggett, J. E., B. Fantin, S. Ebert, K. Totsuka, B. Vogelman, W. Calame, H. Mattie, and W. A. Craig. 1989. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis. 159:281-292.
9. Löwdin, E., I. Odenholt-Tornqvist, and O. Cars. 1993. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrob. Agents Chemother. 37:2200-2205.
10. McDonald, P. J., W. A. Craig, and C. M. Kunin. 1977. Persistent effects of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J. Infect. Dis. 135:217-223.
11. Merck & Co. Data on file.
12. Moellering, R. C., Jr., G. M. Eliopoulos, and D. E. Sentochnil. 1989. The carbapenems: new broad spectrum β-lactam antibiotics. J. Antimicrob. Chemother. 24(Suppl. A):1-7.
13. Nadler, H. I., D. H. Pitkin, and W. Sheikh. 1989. The postantibiotic effect of meropenem and imipenem on selected bacteria. J. Antimicrob. Chemother. 24(Suppl. A):225-231.
14. Odenholt, I., B. Isaksson, L. Nilsson, and O. Cars. 1989. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur. J. Clin. Bacteriol. Infect. Dis. 8:136-141.
15. Odenholt, I., S. E. Holm, and O. Cars. 1989. Effects of benzylpenicillin on group A β-hemolytic streptococci during the postantibiotic phase in vitro. J. Antimicrob. Chemother. 24:147-156.
16. Odenholt, I., S. E. Holm, and O. Cars. 1990. Effects of supra- and sub-MIC benzylpenicillin concentrations on group A β-hemolytic streptococci during the postantibiotic phase in vivo. J. Antimicrob. Chemother. 26:193-201.
17. Odenholt, I., E. Löwdin, and O. Cars. 1997. Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against gram-positive and gram-negative bacteria. Clin. Microbiol. Infect. 3:73-81.
18. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1991. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
19. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1992. Postantibiotic subMIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36:1852-1858.
20. Odenholt-Tornqvist, I. 1993. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem. J. Antimicrob. Chemother. 31: 881-892.
21. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1995. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrob. Agents Chemother. 39:221-226.
22. Vogelman, B., and W. A. Craig. 1986. Kinetics of antimicrobial activity. J. Pediatr. 108:835-840.
23. Vogelman, B., S. Gudmundsson, J. Turnidge, J. Leggett, and W. A. Craig. 1988. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J. Infect. Dis. 157:287-298.
24. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.
25. Wilson, D. A., and G. N. Rolinson. 1979. The recovery period following exposure of bacteria to penicillin. Chemotherapy (Basel) 25:14-22.